Results 61 to 70 of about 50,619 (166)

Narrative Review of the Role of Nondepolarizing Neuromuscular Blocking Agents in Anesthesia: Perspective 2026. [PDF]

Med Sci Monit
Radkowski P, Rafałowicz A, Wojciechowka UJ, Muża M, Marczuk K, Mamala M, Grabarczyk Ł.   +6 more
europepmc   +1 more source

Anesthetic Management of a Patient With Hereditary Spastic Paraplegia: A Case Report. [PDF]

Case Rep Anesthesiol
Sotelo I, Olsen KR.
europepmc   +1 more source

Neuromuscular block in paediatric patients undergoing airway management: a narrative review. [PDF]

Curr Opin Anaesthesiol
Bonfiglio R, von Eichstedt H, Fuchs A, Disma N, Riva T.   +4 more
europepmc   +1 more source

Postoperative pulmonary complications after neuromuscular blockade: what does the recent evidence demonstrate? [PDF]

J Thorac Dis
Maisat W, Yuki K.
europepmc   +1 more source

NEUROMUSCULAR TOXICITY OF ANTICHOLINESTERASE AGENTS

The Journal of Toxicological Sciences, 1998
openaire   +3 more sources

Navigating Anxiety Management in Myasthenia Gravis Crisis With Prolonged Corrected QT (QTc): A Case Report. [PDF]

Cureus
Burky G.
europepmc   +1 more source

Neuromuscular Blocking Agents

Neuromuscular Blocking Agents (NMBAs) are essential in anesthesia for muscle relaxation during surgical procedures. They are classified into non-depolarizing and depolarizing agents, with depolarizing agents activating acetylcholine receptors and non-depolarizing agents blocking them.
openaire   +2 more sources

Toward reliable neuromuscular blockade reversal using sugammadex in infants: insights from a phase IV trial. [PDF]

Transl Pediatr
Jung JY, Sung TY.
europepmc   +1 more source

Ocular Adverse Events Associated With Antidepressants: A Large-Scale Data Analysis From the FAERS Database. [PDF]

CNS Neurosci Ther
Peng Y, Cao Y, Liu H, Ma J, Yang G.
europepmc   +1 more source

Current recommendations for preventing residual neuromuscular blockade. [PDF]

Anesth Pain Med (Seoul)
Lee JE, Jung H.
europepmc   +1 more source